摘要
目的:研究在宫腔镜下活检、诊断性刮宫术前病理检查方法联合血清CA125在诊断子宫癌肉瘤的价值分析。方法:选取从2014年6月~2016年6月某院收治并确诊为子宫癌肉瘤的患者124例,分析其在病前所做的诊断。结果:病理诊断结果Ⅰ期51例,Ⅱ期19例,Ⅲ期40例,Ⅳ期14例,宫腔镜下活检、诊断性刮宫术检验结果与病理诊断无明显差异(P>0.05);血清CA125结果显示,血清CA125升高主要与附件转移有关。结论:宫腔镜活检和诊断性刮宫术在诊断子宫癌肉瘤无显著性差异,血清CA125水平升高主要与附件转移有关,当血清CA125升高应优先考虑附件转移,血清CA125检测可为辅助检验方案。
Objective:To study the value of hysteroscopic biopsy,diagnostic hysteropathological examination before curettage combined with serum CA125 in the diagnosis of uterine carcinosarcoma.Methods:124 patients with uterine carcinosarcoma admitted to a hospital and diagnosed with uterine carcinosarcoma from June 2014 to June 2016 were selected to analyze the diagnosis before the disease.Results:Pathological diagnosis results showed thatⅠperiod 51 cases,Ⅱperiod 19 cases,Ⅲperiod 40 cases,Ⅳperiod 14 cases,biopsy,diagnostic curettage under hysteroscopy surgery inspection results and pathological diagnosis has no significant difference(P>0.05);According to the results of serum CA125,elevated serum CA125 is mainly related to the attachment transfer.Conclusion:There is no significant difference between hysteroscopic biopsy and diagnostic hysterectomy in the diagnosis of uterine carcinosarcoma.The increase of serum CA125 level is mainly related to the metastasis of the appendix.When serum CA125 is increased,the metastasis of the appendix should be given priority,the serum CA125 test can be used as an auxiliary test.
作者
李菲
Li Fei(Department of Pathology,Kaifeng Maternal and Child Health Care Hospital,Kaifeng 475000)
出处
《数理医药学杂志》
2020年第3期350-351,共2页
Journal of Mathematical Medicine